Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.

DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, DuPont MW, Martinez-Sandoval F.

Ann Intern Med. 2005 May 17;142(10):805-12. Erratum in: Ann Intern Med. 2005 Aug 2;143(3):239.

PMID:
15897530
2.

Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis.

Alajbegovic S, Sanders JW, Atherly DE, Riddle MS.

Syst Rev. 2012 Aug 28;1:39. doi: 10.1186/2046-4053-1-39. Review.

3.

Rifaximin: a new treatment for travelers' diarrhea.

Pakyz AL.

Ann Pharmacother. 2005 Feb;39(2):284-9. Epub 2004 Dec 14. Review.

PMID:
15598963
4.

Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.

Koo HL, DuPont HL.

Curr Opin Gastroenterol. 2010 Jan;26(1):17-25. doi: 10.1097/MOG.0b013e328333dc8d. Review.

5.

Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections.

Gerard L, Garey KW, DuPont HL.

Expert Rev Anti Infect Ther. 2005 Apr;3(2):201-11. Review.

PMID:
15918778
6.

Current and future developments in travelers' diarrhea therapy.

Koo HL, DuPont HL.

Expert Rev Anti Infect Ther. 2006 Jun;4(3):417-27. Review.

PMID:
16771619
7.

Current concepts in travelers' diarrhea: epidemiology, antimicrobial resistance and treatment.

Okhuysen PC.

Curr Opin Infect Dis. 2005 Dec;18(6):522-6. Review.

PMID:
16258326
8.

Rifaximin: new therapeutic indication and future directions.

Rivkin A, Gim S.

Clin Ther. 2011 Jul;33(7):812-27. doi: 10.1016/j.clinthera.2011.06.007. Epub 2011 Jul 7. Review.

PMID:
21741091
9.

Travelers' diarrhea.

Hill DR, Beeching NJ.

Curr Opin Infect Dis. 2010 Oct;23(5):481-7. doi: 10.1097/QCO.0b013e32833dfca5. Review.

PMID:
20683261
10.

Travelers' diarrhea: antimicrobial therapy and chemoprevention.

DuPont HL.

Nat Clin Pract Gastroenterol Hepatol. 2005 Apr;2(4):191-8; quiz 1 p following 198. Review.

PMID:
16265184
11.

Antimicrobial prophylaxis of travelers' diarrhea: a selected summary.

Sack RB.

Rev Infect Dis. 1986 May-Jun;8 Suppl 2:S160-6. Review.

PMID:
3523712
12.

Rifaximin: a review of its use in the management of traveller's diarrhoea.

Robins GW, Wellington K.

Drugs. 2005;65(12):1697-713. Review.

PMID:
16060706
13.

[Travelers' diarrhea].

Markwalder K.

Ther Umsch. 2001 Jun;58(6):367-71. Review. German.

PMID:
11441697
14.

New insights and directions in travelers' diarrhea.

DuPont HL.

Gastroenterol Clin North Am. 2006 Jun;35(2):337-53, viii-ix. Review.

PMID:
16880069
15.

Rifaximin: a nonabsorbed antimicrobial as a new tool for treatment of travelers' diarrhea.

Steffen R.

J Travel Med. 2001 Dec;8(Suppl 2):S34-9. Review. No abstract available.

16.

Rifaximin--a novel antimicrobial for enteric infections.

Huang DB, DuPont HL.

J Infect. 2005 Feb;50(2):97-106. Review.

PMID:
15667909
17.

Rifaximin: a nonabsorbed oral antibiotic.

Baker DE.

Rev Gastroenterol Disord. 2005 Winter;5(1):19-30. Review.

PMID:
15741929
18.

Travelers' diarrhea: microbiologic bases for prevention and treatment.

Sack RB.

Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S59-63. Review.

PMID:
2406857
19.

Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.

Rivkin A, Rybalov S.

Pharmacotherapy. 2016 Mar;36(3):300-16. doi: 10.1002/phar.1712. Epub 2016 Mar 11. Review.

PMID:
26971716
20.

What's new in enteric infectious diseases at home and abroad.

DuPont HL.

Curr Opin Infect Dis. 2005 Oct;18(5):407-12. Review.

PMID:
16148527

Supplemental Content

Support Center